Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,976,580
in 4 filings, $5.0M under 10b5-1 plans

Net −$4,976,580. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Loeillot Olivier −$5.0M Chief Executive Officer sold 37% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-03-24 Cox John Director Sale −1,858 $96.72 $180K 923
2020-03-18 Cox John Director Exercise or conversion +14,000 $12.91 $181K 16,781
2020-03-18 Cox John Director Exercise or conversion +3,632 $41.19 $150K 20,413
2020-03-18 Cox John Director Exercise or conversion +3,366 $26.12 $88K 23,779
2020-03-18 Cox John Director Exercise or conversion +2,434 $38.76 $94K 26,213
2020-03-18 Cox John Director Exercise or conversion +3,304 $42.07 $139K 29,517
2020-03-18 Cox John Director Sale −24,533 $95.13 $2.3M 4,984
2020-03-18 Cox John Director Sale −1,187 $96.45 $114K 3,797
2020-03-18 Cox John Director Sale −1,016 $97.17 $99K 2,781
2020-03-18 Cox John Director Exercise or conversion · Stock Option (Right to Buy) −14,000 0
2020-03-18 Cox John Director Exercise or conversion · Stock Option (Right to Buy) −3,632 0
2020-03-18 Cox John Director Exercise or conversion · Stock Option (Right to Buy) −3,366 0
2020-03-18 Cox John Director Exercise or conversion · Stock Option (Right to Buy) −2,434 0
2020-03-18 Cox John Director Exercise or conversion · Stock Option (Right to Buy) −3,304 0
2020-03-04 Cox John Director Exercise or conversion +10,000 $12.91 $129K 12,781
2020-03-04 Cox John Director Sale −10,000 $93.39 $934K 2,781
2020-03-04 Cox John Director Exercise or conversion · Stock Option (Right to Buy) −10,000 14,000
2020-02-24 Cox John Director Sale −100 $94.85 $9K 7,136
2020-02-24 Cox John Director Sale −4,355 $92.76 $404K 2,781
2019-05-15 Cox John Director Grant or award +923 7,236

Page 1 of 2 · 21 trades